IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $298,000 | +20.2% | 9,050 | 0.0% | 0.05% | +10.2% |
| Q2 2020 | $248,000 | -41.1% | 9,050 | -35.6% | 0.05% | -51.0% |
| Q1 2020 | $421,000 | +1.7% | 14,050 | -6.1% | 0.10% | +23.5% |
| Q4 2019 | $414,000 | +9.8% | 14,970 | -27.8% | 0.08% | +5.2% |
| Q3 2019 | $377,000 | -25.8% | 20,725 | 0.0% | 0.08% | -25.2% |
| Q2 2019 | $508,000 | +157.9% | 20,725 | 0.0% | 0.10% | +151.2% |
| Q1 2019 | $197,000 | +7.7% | 20,725 | 0.0% | 0.04% | -2.4% |
| Q4 2018 | $183,000 | -21.5% | 20,725 | 0.0% | 0.04% | -10.6% |
| Q3 2018 | $233,000 | -12.1% | 20,725 | 0.0% | 0.05% | -11.3% |
| Q2 2018 | $265,000 | -24.3% | 20,725 | 0.0% | 0.05% | -26.4% |
| Q1 2018 | $350,000 | +212.5% | 20,725 | +47.5% | 0.07% | +213.0% |
| Q4 2017 | $112,000 | +2.8% | 14,050 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $109,000 | – | 14,050 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |